Skip to content

Influence of Medication Taste on Pediatric Prescribers' Prescribing Habits

Influence of Medication Palatability on Prescribing Habits of Pediatric Prescribers

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01734759
Enrollment
50
Registered
2012-11-28
Start date
2012-11-30
Completion date
2013-01-31
Last updated
2013-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

medication palatability, medication taste

Brief summary

The purpose of this study is to see if a medication taste test influences the prescribing habits of pediatric prescribers at Mayo Clinic.

Interventions

Before the taste test each participant will fill out an informed consent form and an enrollment survey. Each participant will receive 0.5 mL of each study medication in the taste test. During the taste test each medication in a class will be labeled with a color name so as to prevent any bias from preconceived taste perception. They will record their perception of the medications taste on a visual analog scale (VAS). An anaphlyaxis kit will be on hand in case of emergencies. Between samples participants will cleanse their palate with a saltine cracker and 30 mL of water. 5 different classes of medications will be tested. Medications to be sampled and the corresponding dose of the test dose are: * Cephalosporins: cefdinir 12.5 mg, cefixime 10 mg * Penicillins: penicillin VK 12.5 mg, amoxicillin 12.5 mg * Analgesic/antipyretics: acetaminophen 16 mg, ibuprofen 10 mg * Steroids: prednisolone 1.5 mg, prednisone 0.5 mg * H2 receptor blockers: famotidine 4 mg, ranitidine 7.5 mg

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* subjects possess prescriptive authority (e.g. MD, nurse practitioner, physician's assistant, medication therapy management pharmacists) * subjects have prescribed at least one of the study medications from one of the medication classes to pediatric patients at an outpatient clinic in the three months preceding the study

Exclusion criteria

* subjects do not prescribe any of the tested medications * subject has an allergy to all of the study medications * subject is pregnant or breastfeeding * subject has a medical condition that prevents them from being involved in the taste test Participants are advised to be within or accessible to the Rochester, MN area during study recruitment and accessible afterwards via mail, email or fax.

Design outcomes

Primary

MeasureTime frameDescription
Taste scores on the visual analog scaleChange from baseline in taste scores at 3 monthsMedication taste scores on the visual analog scale before and after a medication tasting will be measured.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026